Free Trial

AvePoint, Inc. (NASDAQ:AVPT) Shares Sold by Teachers Retirement System of The State of Kentucky

AvePoint logo with Computer and Technology background

Teachers Retirement System of The State of Kentucky reduced its holdings in shares of AvePoint, Inc. (NASDAQ:AVPT - Free Report) by 16.8% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 82,781 shares of the company's stock after selling 16,742 shares during the period. Teachers Retirement System of The State of Kentucky's holdings in AvePoint were worth $1,195,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. M&T Bank Corp boosted its position in shares of AvePoint by 3.0% in the first quarter. M&T Bank Corp now owns 22,058 shares of the company's stock worth $319,000 after purchasing an additional 634 shares during the period. SG Americas Securities LLC boosted its position in shares of AvePoint by 3.1% during the first quarter. SG Americas Securities LLC now owns 30,982 shares of the company's stock worth $447,000 after acquiring an additional 922 shares during the last quarter. Summit Investment Advisors Inc. boosted its position in shares of AvePoint by 8.4% during the fourth quarter. Summit Investment Advisors Inc. now owns 13,475 shares of the company's stock worth $222,000 after acquiring an additional 1,042 shares during the last quarter. Blair William & Co. IL boosted its position in shares of AvePoint by 24.7% during the fourth quarter. Blair William & Co. IL now owns 7,563 shares of the company's stock worth $125,000 after acquiring an additional 1,500 shares during the last quarter. Finally, Heck Capital Advisors LLC bought a new position in shares of AvePoint during the fourth quarter worth $29,000. 44.49% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on AVPT. Jefferies Financial Group assumed coverage on shares of AvePoint in a research report on Monday. They set a "buy" rating and a $22.00 target price for the company. The Goldman Sachs Group increased their price objective on shares of AvePoint from $15.00 to $17.00 and gave the company a "neutral" rating in a research report on Monday, May 12th. Finally, Scotiabank increased their price objective on shares of AvePoint from $19.00 to $22.00 and gave the company a "sector outperform" rating in a research report on Friday, May 9th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $18.17.

Get Our Latest Stock Report on AvePoint

AvePoint Stock Up 0.3%

AVPT stock traded up $0.06 during trading on Friday, hitting $18.56. The company had a trading volume of 885,007 shares, compared to its average volume of 1,115,773. The firm has a market capitalization of $3.77 billion, a P/E ratio of -142.76 and a beta of 1.33. AvePoint, Inc. has a 52-week low of $9.38 and a 52-week high of $20.25. The company has a 50 day simple moving average of $18.73 and a 200-day simple moving average of $17.26.

Insider Activity

In other AvePoint news, insider Brian Michael Brown sold 35,000 shares of the firm's stock in a transaction dated Wednesday, July 23rd. The shares were sold at an average price of $18.74, for a total transaction of $655,900.00. Following the transaction, the insider owned 1,190,443 shares of the company's stock, valued at approximately $22,308,901.82. This trade represents a 2.86% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jeff Epstein sold 500,000 shares of AvePoint stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $18.77, for a total transaction of $9,385,000.00. Following the completion of the transaction, the director directly owned 1,157,891 shares in the company, valued at approximately $21,733,614.07. The trade was a 30.16% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 605,000 shares of company stock worth $11,315,600 in the last ninety days. 26.19% of the stock is currently owned by insiders.

About AvePoint

(Free Report)

AvePoint, Inc provides cloud-native data management software platform in North America, Europe, Middle East, Africa, and Asia Pacific. It also offers software-as-a-service solutions and productivity applications. The company offers modularity and cloud services architecture to address critical challenges and the management of data to organizations that leverage third-party cloud vendors, including Microsoft, Salesforce, Google, AWS, Box, DropBox, and others; license and support; and maintenance services.

Further Reading

Institutional Ownership by Quarter for AvePoint (NASDAQ:AVPT)

Should You Invest $1,000 in AvePoint Right Now?

Before you consider AvePoint, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AvePoint wasn't on the list.

While AvePoint currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines